These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37236430)

  • 1. Switching to Intravenous Methadone in Advanced Cancer Patients: A Retrospective Analysis.
    Mercadante S; Cascio AL; Casuccio A
    J Pain Symptom Manage; 2023 Oct; 66(4):287-292. PubMed ID: 37236430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Titration With Intravenous Oxycodone for Severe Cancer Pain and Oral Conversion Ratio.
    Mercadante S; Adile C; Ferrera P; Cascio AL; Casuccio A
    J Pain Symptom Manage; 2022 Dec; 64(6):532-536. PubMed ID: 36115502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
    Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
    J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching from methadone to a different opioid: what is the equianalgesic dose ratio?
    Walker PW; Palla S; Pei BL; Kaur G; Zhang K; Hanohano J; Munsell M; Bruera E
    J Palliat Med; 2008 Oct; 11(8):1103-8. PubMed ID: 18980450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid switching between transdermal fentanyl and methadone in cancer patients.
    Mercadante S; Ferrera P; Villari P; Casuccio A
    J Clin Oncol; 2005 Aug; 23(22):5229-34. PubMed ID: 16051965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two techniques (intermittent intravenous bolus morphine vs. morphine infusion) for analgesic titration in patients who had advanced cancer with severe pain: a prospective randomised study.
    Kumar V; Sirohiya P; Garg R; Gupta N; Bharti SJ; Velpandian T; Mishra S; Bhatnagar S
    BMJ Support Palliat Care; 2023 Sep; 13(3):338-344. PubMed ID: 32895226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion ratios for opioid switching: a pragmatic study.
    Mercadante S; Adile C; Ferrera P; Grassi Y; Cascio AL; Casuccio A
    Support Care Cancer; 2022 Dec; 31(1):91. PubMed ID: 36580152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit.
    Mercadante S
    Pain Med; 2012 Mar; 13(3):399-404. PubMed ID: 22360828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of oral versus intravenous methadone on postoperative pain and opioid use after adult spinal deformity surgery: A retrospective, non-inferiority analysis.
    Esfahani K; Tennant W; Tsang S; Naik BI; Dunn LK
    PLoS One; 2023; 18(7):e0288988. PubMed ID: 37478144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid plasma concentration during switching from morphine to methadone: preliminary data.
    Mercadante S; Bianchi M; Villari P; Ferrera P; Casuccio A; Fulfaro F; Gebbia V
    Support Care Cancer; 2003 May; 11(5):326-31. PubMed ID: 12690541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone as First-line Opioid for the Management of Cancer Pain.
    Mercadante S; Adile C; Ferrera P; Pallotti MC; Ricci M; Bonanno G; Casuccio A
    Oncologist; 2022 Apr; 27(4):323-327. PubMed ID: 35380722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
    Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
    J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching from oxycodone to methadone in advanced cancer patients.
    Mercadante S; Ferrera P; Villari P; Adile C; Casuccio A
    Support Care Cancer; 2012 Jan; 20(1):191-4. PubMed ID: 21901297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?
    Ripamonti C; Groff L; Brunelli C; Polastri D; Stavrakis A; De Conno F
    J Clin Oncol; 1998 Oct; 16(10):3216-21. PubMed ID: 9779694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid use and effectiveness of its prescription at discharge in an acute pain relief and palliative care unit.
    Mercadante S; Prestia G; Ranieri M; Giarratano A; Casuccio A
    Support Care Cancer; 2013 Jul; 21(7):1853-9. PubMed ID: 23400316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid-induced hyperalgesia after rapid titration with intravenous morphine: Switching and re-titration to intravenous methadone.
    Mercadante S; Ferrera P; Arcuri E; Casuccio A
    Ann Palliat Med; 2012 Apr; 1(1):10-3. PubMed ID: 25841426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose ratios between high dose oral morphine or equivalents and oral methadone.
    Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
    J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone titration in opioid-resistant cancer pain.
    Scholes CF; Gonty N; Trotman IF
    Eur J Cancer Care (Engl); 1999 Mar; 8(1):26-9. PubMed ID: 10362950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.